The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer (Q35064038)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer (English)

1 reference

Europe PubMed Central

6 August 2017

Johannes Pieter Albert Baak

13

object named as

Jan P A Baak

1 reference

Europe PubMed Central

6 August 2017

10

object named as

Ivar Skaland

1 reference

Europe PubMed Central

6 August 2017

Emiel A M Janssen

8

object named as

Emiel A M Janssen

1 reference

Europe PubMed Central

6 August 2017

Per-Uno Malmström

12

object named as

Per Malmström

1 reference

Europe PubMed Central

6 August 2017

Einar G Gudlaugsson

7

object named as

Einar Gudlaugsson

1 reference

Europe PubMed Central

6 August 2017

author name string

Marie Klintman

1

1 reference

Europe PubMed Central

6 August 2017

Carina Strand

2

1 reference

Europe PubMed Central

6 August 2017

Cecilia Ahlin

3

1 reference

Europe PubMed Central

6 August 2017

Sanda Beglerbegovic

4

1 reference

Europe PubMed Central

6 August 2017

Marie-Louise Fjällskog

5

1 reference

Europe PubMed Central

6 August 2017

Dorthe Grabau

6

1 reference

Europe PubMed Central

6 August 2017

Kristina Lövgren

9

1 reference

Europe PubMed Central

6 August 2017

Pär-Ola Bendahl

11

1 reference

Europe PubMed Central

6 August 2017

Mårten Fernö

14

1 reference

Europe PubMed Central

6 August 2017

language of work or name

0 references

publication date

4 December 2013

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

8

1 reference

Europe PubMed Central

6 August 2017

12

1 reference

Europe PubMed Central

6 August 2017

e81902

1 reference

Europe PubMed Central

6 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

4 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Evaluation of 5 different labeled polymer immunohistochemical detection systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Histological grading in breast cancer: interobserver agreement, and relation to other prognostic factors including ploidy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

8 July 2018

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

27 September 2018

The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852976

27 September 2018

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0081902

21 January 2018

Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of a morphometric prognostic index in female breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0081902

1 reference

Europe PubMed Central

6 August 2017

2013PLoSO...881902K

0 references

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35064038&oldid=1863344774"